Literature DB >> 16648531

Antidepressant therapy and C-reactive protein levels.

Sinead M O'Brien1, Lucinda V Scott, Timothy G Dinan.   

Abstract

BACKGROUND: Major depression is associated with activation of the inflammatory response. AIMS: To examine C-reactive protein levels in depression and to determine the impact of selective serotonin reuptake inhibitor (SSRI) therapy.
METHOD: A two-part study. In study 1, which used a between-subjects design, C-reactive protein was measured in 32 patients (20 currently depressed, 12 euthymic) with a history of DSM-IV major depression, all of whom were treated with an SSRI, and in a healthy comparison group (n = 20). Study 2 employed a within-subject design: C-reactive protein was measured in 20 patients with major depression both before and after SSRI treatment.
RESULTS: In study 1, C-reactive protein levels did not differ between the group with depressive disorder (either currently depressed or euthymic) treated with SSRIs and the healthy group. In study 2 the protein levels dropped significantly following treatment with antidepressant medication.
CONCLUSIONS: Following SSRI treatment for major depression there is a significant drop in C-reactive protein concentrations whether or not the depression resolves. These findings indicate that antidepressants induce an anti-inflammatory response independent of antidepressant action.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648531     DOI: 10.1192/bjp.bp.105.011015

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  45 in total

Review 1.  Poststroke depression: a review.

Authors:  Robert G Robinson; Gianfranco Spalletta
Journal:  Can J Psychiatry       Date:  2010-06       Impact factor: 4.356

Review 2.  Neuroinflammation and comorbidity of pain and depression.

Authors:  A K Walker; A Kavelaars; C J Heijnen; R Dantzer
Journal:  Pharmacol Rev       Date:  2013-12-11       Impact factor: 25.468

3.  Salivary C-reactive protein among at-risk adolescents: A methods investigation of out of range immunoassay data.

Authors:  E R Landau; J Trinder; J G Simmons; M Raniti; M Blake; J M Waloszek; L Blake; O Schwartz; G Murray; N B Allen; M L Byrne
Journal:  Psychoneuroendocrinology       Date:  2018-09-08       Impact factor: 4.905

4.  The association of serum C-reactive protein with the occurrence and course of postpartum depression.

Authors:  Emily S Miller; Denada Hoxha; Emily Pinheiro; William A Grobman; Katherine L Wisner
Journal:  Arch Womens Ment Health       Date:  2018-04-13       Impact factor: 3.633

Review 5.  The impact of vascular burden on late-life depression.

Authors:  Micaela Santos; Enikö Kövari; Patrick R Hof; Gabriel Gold; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Brain Res Rev       Date:  2009-09-08

Review 6.  Integrating neuroimmune systems in the neurobiology of depression.

Authors:  Eric S Wohleb; Tina Franklin; Masaaki Iwata; Ronald S Duman
Journal:  Nat Rev Neurosci       Date:  2016-06-09       Impact factor: 34.870

Review 7.  Antidepressants in inflammatory bowel disease.

Authors:  Antonina Mikocka-Walus; Alexander C Ford; Douglas A Drossman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-18       Impact factor: 46.802

8.  Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression.

Authors:  H A Eyre; H Lavretsky; J Kartika; A Qassim; B T Baune
Journal:  Pharmacopsychiatry       Date:  2016-03-07       Impact factor: 5.788

9.  Waist circumference and BMI in relation to serum high sensitivity C-reactive protein (hs-CRP) in Cuban Americans with and without type 2 diabetes.

Authors:  Fatma G Huffman; Suzanne Whisner; Gustavo G Zarini; Subrata Nath
Journal:  Int J Environ Res Public Health       Date:  2010-03-08       Impact factor: 3.390

10.  Anti-inflammatory effects of antidepressant and atypical antipsychotic medication for the treatment of major depression and comorbid arthritis: a case report.

Authors:  Bernhard T Baune; Harris Eyre
Journal:  J Med Case Rep       Date:  2010-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.